Big year coming in 2022. Early results show efficacy and no problems with healthy cells. Successful trials with any one of the targeted diseases will send this off the richter scale.
Patience required. After 10 years, I can wait.
- Forums
- ASX - By Stock
- IVX
- Ann: AGM Presentation
IVX
invion limited
Add to My Watchlist
0.00%
!
13.5¢

Ann: AGM Presentation, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
13.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.43M |
Open | High | Low | Value | Volume |
13.5¢ | 13.5¢ | 13.5¢ | $4.65K | 34.44K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 119627 | 12.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
13.5¢ | 56138 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 27571 | 0.125 |
3 | 209200 | 0.120 |
2 | 227489 | 0.115 |
3 | 20320 | 0.105 |
5 | 65300 | 0.100 |
Price($) | Vol. | No. |
---|---|---|
0.135 | 78750 | 2 |
0.140 | 25770 | 2 |
0.145 | 92607 | 3 |
0.150 | 146065 | 4 |
0.155 | 110008 | 2 |
Last trade - 10.07am 18/06/2025 (20 minute delay) ? |
Featured News
IVX (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online